GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
GLOBUS MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$75.65−1.06 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $10.39B
- P/E (TTM)
- 19.3
- Dividend yield
- –
Share price
+$16.07 (+26.97%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
GLOBUS MEDICAL INC grew revenue 19.7% to $3.14B over the twelve months to Jun 30, 2026. Operating income rose 127.2% to $639.52M, moving the operating margin from 10.7% to 20.3%. Free cash flow was $755.59M, up 43.3% from a year earlier.
Revenue
$3.14B
+19.7% vs. a year earlier
Operating income
$639.52M
+127.2% vs. a year earlier
Free cash flow
$755.59M
+43.3% vs. a year earlier
EPS, diluted
$3.91
+50.4% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $10.39B
- P/E ratio
- 19.3
- Price to sales
- 3.30
- Price to book
- 2.18
- Dividend yield
- –
- Free cash flow yield
- 7.27%
Fundamentals
- Revenue
- $3.14B
- Net income
- $535.43M
- EPS, diluted
- $3.91
- Free cash flow
- $755.59M
- Book value per share
- $34.71
- Diluted shares
- 137M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$3.14B+19.7% YoY
Gross profit
$2.16B+30.8% YoY
Operating income
$639.52M+127.2% YoY
Net income
$535.43M+50.1% YoY
EPS, diluted
$3.91+50.4% YoY
Free cash flow
$755.59M+43.3% YoY
Reported periodTrailing twelve months